JPWO2023100740A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023100740A5 JPWO2023100740A5 JP2023564919A JP2023564919A JPWO2023100740A5 JP WO2023100740 A5 JPWO2023100740 A5 JP WO2023100740A5 JP 2023564919 A JP2023564919 A JP 2023564919A JP 2023564919 A JP2023564919 A JP 2023564919A JP WO2023100740 A5 JPWO2023100740 A5 JP WO2023100740A5
- Authority
- JP
- Japan
- Prior art keywords
- patch according
- mass
- styrene
- adhesive layer
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims 8
- 239000012790 adhesive layer Substances 0.000 claims 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims 5
- 229930195729 fatty acid Natural products 0.000 claims 5
- 239000000194 fatty acid Substances 0.000 claims 5
- -1 fatty acid ester Chemical class 0.000 claims 5
- 239000003589 local anesthetic agent Substances 0.000 claims 5
- 229920002725 thermoplastic elastomer Polymers 0.000 claims 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- 229920001400 block copolymer Polymers 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 229920000346 polystyrene-polyisoprene block-polystyrene Polymers 0.000 claims 3
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 claims 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 claims 1
- WZSPWMATVLBWRS-UHFFFAOYSA-N 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide;n-(2-methylphenyl)-2-(propylamino)propanamide Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C WZSPWMATVLBWRS-UHFFFAOYSA-N 0.000 claims 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 claims 1
- 229960005274 benzocaine Drugs 0.000 claims 1
- 229960003150 bupivacaine Drugs 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 150000002148 esters Chemical group 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 claims 1
- 229960004288 levobupivacaine Drugs 0.000 claims 1
- LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 claims 1
- 229960004194 lidocaine Drugs 0.000 claims 1
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 1
- 229960002409 mepivacaine Drugs 0.000 claims 1
- INWLQCZOYSRPNW-UHFFFAOYSA-N mepivacaine Chemical compound CN1CCCCC1C(=O)NC1=C(C)C=CC=C1C INWLQCZOYSRPNW-UHFFFAOYSA-N 0.000 claims 1
- 229960001807 prilocaine Drugs 0.000 claims 1
- MVFGUOIZUNYYSO-UHFFFAOYSA-N prilocaine Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C MVFGUOIZUNYYSO-UHFFFAOYSA-N 0.000 claims 1
- 229960001549 ropivacaine Drugs 0.000 claims 1
- 125000003011 styrenyl group Chemical group [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229960002372 tetracaine Drugs 0.000 claims 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 claims 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021196430 | 2021-12-02 | ||
| JP2022179851 | 2022-11-09 | ||
| PCT/JP2022/043366 WO2023100740A1 (ja) | 2021-12-02 | 2022-11-24 | 貼付剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023100740A1 JPWO2023100740A1 (enExample) | 2023-06-08 |
| JPWO2023100740A5 true JPWO2023100740A5 (enExample) | 2024-08-15 |
Family
ID=86612095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564919A Pending JPWO2023100740A1 (enExample) | 2021-12-02 | 2022-11-24 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20250009682A1 (enExample) |
| JP (1) | JPWO2023100740A1 (enExample) |
| WO (1) | WO2023100740A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5985317A (en) * | 1996-09-06 | 1999-11-16 | Theratech, Inc. | Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents |
| ES2223277B1 (es) * | 2003-06-19 | 2006-03-01 | Fernando Bouffard Fita | Composicion anestesica para administracion topica. |
| WO2006017632A1 (en) * | 2004-08-04 | 2006-02-16 | Cassel Douglas R | An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain |
| EP3639819B1 (en) * | 2017-06-16 | 2021-11-10 | Medrx Co., Ltd. | Anti-inflammatory and analgesic drug for external use |
| WO2020184208A1 (ja) * | 2019-03-14 | 2020-09-17 | 株式会社カネカ | 貼付剤 |
-
2022
- 2022-11-24 JP JP2023564919A patent/JPWO2023100740A1/ja active Pending
- 2022-11-24 WO PCT/JP2022/043366 patent/WO2023100740A1/ja not_active Ceased
- 2022-11-24 US US18/710,056 patent/US20250009682A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011046700A5 (enExample) | ||
| US8889736B2 (en) | Formulations for the treatment of pain | |
| JP2010514831A5 (enExample) | ||
| US10406115B2 (en) | Pressure-sensitive adhesives for transdermal drug delivery | |
| JP2017178948A5 (enExample) | ||
| JP2012532887A5 (enExample) | ||
| RU2011133036A (ru) | Способ лечения невропатической боли | |
| NO20081810L (no) | Modulatorer av metabolisme og behandling av lidelser relatert dertil | |
| NZ612686A (en) | Sublingual films | |
| WO2004110423A8 (en) | Anesthetic composition for topical administration comprising lidocaine, prilocaine and tetracaine | |
| ATE511359T1 (de) | Versiegelte essbare folienstreifenpakete und verfahren zu ihrer herstellung und verwendung | |
| JPWO2023100740A5 (enExample) | ||
| HRP20180079T1 (hr) | Transdermalni sustav za isporuku | |
| JP2005511564A5 (enExample) | ||
| ATE442349T1 (de) | Diacylglycerol-acyltransferase-hemmer | |
| WO2008088039A1 (ja) | ドネペジルを含有する安定化医薬組成物、その製造方法、及び安定化方法 | |
| CA2584060A1 (fr) | Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement du trouble anxiete generalisee | |
| Ning | Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B | |
| NO20065880L (no) | 3-Amino-l-arylpropylindoler som monoamin-gjenopptagelsesinhibitor | |
| JP2024026109A5 (enExample) | ||
| US20030199479A1 (en) | Oxa(thia)zolidine derivative and anti-inflammatory drug | |
| NO20063809L (no) | Belagte minitabletter av venlaflaxin hydroklorid med forlenget virkning | |
| CA2533749A1 (en) | Piperidine compounds useful as malonyl-coa decarboxylase inhibitors | |
| JP2007501270A5 (enExample) | ||
| Govil et al. | Intraperitoneal levobupivacaine with or without clonidine for pain relief after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial |